Total Live Articles: 471

Cluster Headache

NICE Clinical guideline [CG150] Headaches in over 12s: diagnosis and management. Last updated Dec 2021.

NICE CKS Headache – cluster. Last revised Apr 2022.

Cluster Headache

Cluster headache is the most common trigeminal autonomic cephalalgia and a primary headache disorder, meaning it is not caused by another underlying condition.

This updated UKMLA guide to cluster headache is based on NICE CG150, which covers causes, risk factors, symptoms, diagnosis, and management.

Causes and Risk Factors

The exact cause and underlying pathophysiology of cluster headache are complex and not well understood

  • It is thought to involve hypothalamic dysregulation, trigeminal pain pathways and cranial autonomic activation

Risk factors:

  • More common in males
  • Family history (esp. 1st degree relative with cluster headache)

Environmental factors may trigger an acute attack:

  • Alcohol
  • Smoking
  • Histamine
  • Nitrate-containing food (e.g. cured meat)
  • Smell of volatile substances (e.g. petrol, paint, perfume, nail varnish)

Headache Red Flags

If the headache has ANY of the following red flags, consider the need for further investigations and/or referral:

Category Red Flag Explanation
Infection / inflammation Worsening headache with fever Suggests possible central nervous system infection (e.g., meningitis, encephalitis) or inflammatory disease.
Symptoms suggestive of giant cell arteritis (e.g., jaw claudication, age >50, visual symptoms) Points to vasculitis with risk of vision loss or stroke.
Immunocompromised status (HIV, immunosuppressive drugs) Increases risk for opportunistic infections and neoplastic processes.
Vascular / haemorrhagic Sudden-onset headache reaching maximum intensity within 5 minutes (thunderclap) Characteristic of subarachnoid haemorrhage, reversible cerebral vasoconstriction syndrome, or other acute vascular events.
New-onset neurological deficit May indicate stroke, intracranial mass, encephalitis, or other structural or metabolic brain disorders.
New cognitive dysfunction, personality change, or impaired level of consciousness Suggests stroke, intracranial mass, encephalitis, or other significant brain pathology.
Raised ICP / structural Headache triggered by cough, valsalva manoeuvre, sneeze, or exercise Can be a sign of increased intracranial pressure (e.g., due to intracranial mass).
Vomiting without other clear cause May reflect increased intracranial pressure or mass effect.
Substantial change in headache characteristics May signal a new secondary process, such as neoplasm or infection.
Intracranial hypotension Orthostatic headache Typical of intracranial hypotension, often due to CSF leak.
Trauma-related Recent head trauma (within 3 months) Raises concern for traumatic intracranial haemorrhage (e.g. subdural haematoma).
Oncology-related Age <20 with history of malignancy Raises suspicion for metastatic or recurrent disease affecting the CNS.
History of malignancy known to metastasise to the brain Increases risk for intracranial metastases.
Ophthalmic emergencies Symptoms/signs of acute narrow-angle glaucoma (painful red eye, visual loss) Requires urgent ophthalmological evaluation.

If there is a new-onset headache with ANY of the following, consider the need for further investigations and/or referral:

  • Immunocompromised (e.g. HIV, use of immunosuppressive drugs)
  • <20 y/o + history of malignancy
  • History of malignancy known to metastasise to the brain
  • Vomiting without other obvious causes

Clinical Features and Diagnosis

Cluster headache, like other primary headache disorders, is primarily a clinical diagnosis.

Consider using a headache diary for at least 8 weeks to help diagnose primary headaches. The patient should record the following:

  • Frequency, duration and severity of headaches
  • Any associated symptoms
  • Possible precipitants
  • Relationship of headaches to menstruation
  • All medications taken to relieve headaches

Do NOT refer people diagnosed with tension‑type headache, migraine, cluster headache or medication-overuse headache for neuroimaging solely for reassurance.

Typical clinical features of cluster headache (at least 5 episodes of the following):

  • Severe or very severeunilateral headache (orbital, supraorbital and/or temporal pain), and
  • Duration: 15 min-3 hours (if untreated), and
  • Sense of restlessness or agitation (typically walking up and down, pacing, clutching the affected side)
  • Ipsilateral autonomic features:
    • Conjunctival injection and/or lacrimation
    • Eyelid swelling
    • Miosis and/or ptosis (partial Horner’s syndrome)
    • Nasal congestion and/or rhinorrhoea
    • Forehead and facial sweating
    • Forehead and facial flushing
    • Sensation of fullness in the ear
  • The attacks may wake the person from sleep, about 1.5–2 hours after falling asleep

Cluster headache attacks occur in series, usually lasting 2 weeks-3 months (cluster periods or ’bouts’)

Trigeminal Autonomic Cephalalgias

Cluster headache is the most common trigeminal autonomic cephalalgia – a group of primary headache disorders characterised by unilateral trigeminal-distribution head/facial pain with ipsilateral cranial autonomic features.

Disorder Classic clinical patterns
Cluster headache
  • Severe/very severe unilateral orbital, supraorbital or temporal pain lasting 15-180 min
  • Patient is restless or agitated
  • Ipsilateral autonomic features (e.g. red / watery eye, rhinorrhoea, miosis, ptosis)
Paroxysmal hemicrania Similar to cluster headache but attacks are shorter and more frequent

  • Severe/very severe unilateral orbital, supraorbital or temporal pain lasting 2-30 min
  • Usually occurring>5 times / day
  • Classically resolves with indomethacin
SUNCT / SUNA
  • Very short-lasting headache attacks, lasting seconds to minutes
  • Prominent ipsilateral autonomic features
    • SUNCT = conjunctival injection and tearing
    • SUNA = cranial autonomic symptoms but NOT both conjunctival injection and tearing
Hemicrania continua
  • Continuous unilateral headache lasting >3 months
  • With exacerbations of more severe pain and ipsilateral autonomic features

Management

Acute Management

  • Short-burst oxygen therapy (100% oxygen at >12 L/min with a non-rebreathing mask), AND/OR
    • Home and ambulatory oxygen can be arranged if attacks are recurrent and the diagnosis is clear
  • Subcutaneous or nasal triptan (sumatriptan injection or zolmitriptan intranasal spray)
    • Only for adults>18 y/o
    • Do not offer oral triptans

Discuss the need for neuroimaging for first bout of cluster headache with a specialist.

Triptan is contraindicated in the presence of cardiovascular disorders, previous TIA / CVA, and severe hepatic impairment.

Do not offer paracetamol, NSAIDs, opioids or ergots for acute cluster headache

Prophylactic Management

  • Assess for and manage any underlying triggers or associated conditions (e.g. alcohol, smoking, diet, stress, anxiety, mood disorder)
  • Consider verapamil for prophylaxis

References


Related Articles

Migraine

Tension-Type Headache

Subarachnoid haemorrhage (SAH)

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.